Auna S.A. Class A (AUNA) AI Stock Analysis

• Market Cap: $472.94M
• Dividend Yield: N/A
• Average Volume (3M): 43.47K
• Price to Earnings (P/E): 7.5
• Beta (1Y): 0.97
• Revenue Growth: 2.83%
• EPS Growth: N/A
• Country: US
• Employees: 14,605
• Sector: General
• Sector Strength: N/A
• Industry: Medical - Care Facilities
• EPS (TTM): 0.33
• Shares Outstanding: 30,095,388
• 10 Day Avg. Volume: 46,834
• 30 Day Avg. Volume: 43,465
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 3.10
• Enterprise Value/Revenue: 0.34
• Enterprise Value/Gross Profit: 0.86
• Enterprise Value/Ebitda: 1.33
• 1Y Price Target: $7.00
• Price Target Upside: 5.58% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 69 Neutral
• Price Target: $7.00 ▲(5.58% Upside)

Auna S.A. Class A's overall score is driven by its strong valuation and positive technical indicators. Financial performance is mixed, with solid profitability but concerns over revenue growth and leverage. The earnings call provided a balanced view with notable growth in EBITDA, supporting a positive outlook despite some operational challenges.

Auna S.A. Class A Business Overview & Revenue Model

Company Description

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.

How the Company Makes Money

Auna S.A. makes money through a diversified revenue model centered around its healthcare services and related offerings. The company's key revenue streams include fees for medical services provided at its hospitals and clinics, which encompasses inpatient and outpatient care, surgical procedures, and diagnostic services. Additionally, Auna generates income through insurance plans and prepaid healthcare packages, offering clients a range of coverage options. The company also benefits from strategic partnerships with local and international medical institutions and insurance companies, enhancing its service offerings and expanding its customer base. Furthermore, Auna's investment in healthcare technology and innovation helps optimize operational efficiency and patient satisfaction, contributing positively to its financial performance.

Auna S.A. Class A Financial Statement Overview

Summary

Auna S.A. Class A shows strong profitability margins but faces challenges with declining revenue growth and high leverage. The cash flow statement is a positive aspect, indicating strong cash generation relative to net income.

Income Statement

Auna S.A. Class A has shown a mixed performance in its income statement. The TTM (Trailing-Twelve-Months) data indicates a gross profit margin of 38.89% and a net profit margin of 3.65%, which are relatively healthy. However, the revenue growth rate is negative at -0.61%, indicating a decline in revenue. The EBIT and EBITDA margins are strong at 19.11% and 23.91%, respectively, suggesting efficient operations. Overall, while profitability metrics are solid, the negative revenue growth is a concern.

Balance Sheet

The balance sheet of Auna S.A. Class A reveals a high debt-to-equity ratio of 2.46, indicating significant leverage, which could pose financial risks. The return on equity (ROE) is moderate at 10.61%, reflecting decent profitability relative to shareholder equity. The equity ratio stands at 22.93%, suggesting a moderate level of equity financing. While the company maintains profitability, the high leverage is a potential risk factor.

Cash Flow

Auna S.A. Class A's cash flow statement shows positive trends. The free cash flow growth rate is 5.27%, indicating an improvement in cash generation. The operating cash flow to net income ratio is 0.30, and the free cash flow to net income ratio is 0.76, suggesting that the company is generating sufficient cash relative to its net income. Overall, the cash flow position is strong, with positive growth and adequate coverage ratios.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	4.33B	4.39B	3.88B	2.45B	1.92B	1.44B
Gross Profit	1.70B	1.73B	1.44B	879.70M	686.93M	529.43M
EBITDA	1.10B	975.27M	647.30M	299.14M	170.15M	108.36M
Net Income	237.26M	110.27M	-253.92M	-85.61M	-26.47M	-7.10M
Balance Sheet
Total Assets	7.17B	7.08B	7.69B	6.59B	2.82B	2.65B
Cash, Cash Equivalents and Short-Term Investments	287.11M	335.97M	334.26M	208.69M	138.77M	343.45M
Total Debt	3.70B	3.77B	3.92B	3.51B	1.49B	1.35B
Total Liabilities	5.37B	5.46B	5.91B	5.04B	2.28B	2.00B
Stockholders Equity	1.64B	1.48B	1.47B	1.06B	495.82M	600.93M
Cash Flow
Free Cash Flow	497.19M	577.64M	417.25M	10.67M	-106.03M	27.38M
Operating Cash Flow	648.33M	668.50M	582.41M	162.64M	183.34M	156.30M
Investing Cash Flow	-229.58M	-236.82M	-173.15M	-3.21B	-291.99M	-125.93M
Financing Cash Flow	-394.72M	-418.12M	-370.00M	3.13B	-102.13M	272.70M

Auna S.A. Class A Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 6.63
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AUNA, the sentiment is Positive. The current price of 6.63 is above the 20-day moving average (MA) of 6.37, above the 50-day MA of 6.31, and below the 200-day MA of 6.93, indicating a neutral trend. The MACD of 0.05 indicates Negative momentum. The RSI at 70.75 is Negative, neither overbought nor oversold. The STOCH value of 59.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AUNA.

Auna S.A. Class A Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AUNA	69 Neutral	$472.94M	7.49	15.04%	―	2.83%	―
BTMD	63 Neutral	147.33M	3.30	-2.98%	―	6.32%	344.42%
DCGO	54 Neutral	142.80M	-7.87	-6.16%	―	-41.31%	-163.08%
PIII	48 Neutral	65.33M	-0.19	-178.90%	―	4.20%	-54.16%
CMPS	47 Neutral	518.47M	-3.06	―	―	―	21.30%
CCM	46 Neutral	27.09M	-0.63	13.52%	―	-29.82%	-2.57%
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%

Auna S.A. Class A Corporate Events

Auna S.A. Reports 2Q25 Financial Results with Positive FX-Neutral EBITDA Growth

Auna S.A. reported its financial results for the second quarter of 2025, showing a 5% increase in FX-neutral Adjusted EBITDA year-over-year, despite a 2% decrease in consolidated revenue to S/1,094 million. The company faced foreign exchange challenges, particularly with the depreciation of the Mexican and Colombian currencies against the Peruvian Sol, but all segments contributed positively in local currency terms. Auna’s strategic initiatives in Mexico, Peru, and Colombia have shown progress, with improvements in pricing, service mix, and cost containment. The company aims to optimize its capital structure and maintain its leverage ratio, positioning itself for long-term growth and value creation for stakeholders.

Auna S.A. Expands Regional Presence with Lima Stock Exchange Listing

On July 16, 2025, Auna S.A. announced that its common shares began trading on the Lima Stock Exchange (BVL), marking a strategic move to enhance its regional presence and broaden investor access. This listing, alongside its presence on the New York Stock Exchange, positions Auna as the only healthcare company on the BVL, aiming to improve trading liquidity and increase visibility in Latin America’s capital markets. The dual listing is expected to expand Auna’s institutional investor base and facilitate inclusion in various equity indices, thereby strengthening its market position and offering greater access to Peruvian and regional investors.

Auna S.A. Announces Successful Refinancing by Enfoca

On June 30, 2025, Auna S.A. announced that its controlling shareholder, Enfoca, has successfully refinanced its sponsor-level financing, extending the maturity date to June 2027 with improved economic terms. This refinancing strengthens the alignment between Auna and its pre-IPO shareholders, supporting the company’s strategic growth initiatives in Latin America.